AU6428994A - Formulation for nasal insulin delivery - Google Patents

Formulation for nasal insulin delivery

Info

Publication number
AU6428994A
AU6428994A AU64289/94A AU6428994A AU6428994A AU 6428994 A AU6428994 A AU 6428994A AU 64289/94 A AU64289/94 A AU 64289/94A AU 6428994 A AU6428994 A AU 6428994A AU 6428994 A AU6428994 A AU 6428994A
Authority
AU
Australia
Prior art keywords
formulation
insulin delivery
nasal insulin
nasal
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64289/94A
Inventor
Franciscus W.H.M. Merkus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANCISCUS W H M MERKUS
Original Assignee
FRANCISCUS W H M MERKUS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANCISCUS W H M MERKUS filed Critical FRANCISCUS W H M MERKUS
Publication of AU6428994A publication Critical patent/AU6428994A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU64289/94A 1993-03-26 1994-03-18 Formulation for nasal insulin delivery Abandoned AU6428994A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9300300A BE1006873A6 (en) 1993-03-26 1993-03-26 Administration for drafting nasal insulin delivery.
BE9300300 1993-03-26
PCT/EP1994/000892 WO1994022461A1 (en) 1993-03-26 1994-03-18 Formulation for nasal insulin delivery

Publications (1)

Publication Number Publication Date
AU6428994A true AU6428994A (en) 1994-10-24

Family

ID=3886933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64289/94A Abandoned AU6428994A (en) 1993-03-26 1994-03-18 Formulation for nasal insulin delivery

Country Status (3)

Country Link
AU (1) AU6428994A (en)
BE (1) BE1006873A6 (en)
WO (1) WO1994022461A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
IS1796B (en) * 1993-06-24 2001-12-31 Ab Astra Inhaled polypeptide formulation composition which also contains an enhancer compound
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
FR2827516B1 (en) * 2001-07-19 2003-09-19 Servier Lab PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION OF ESTRADIOL AND NORETHISTERONE
CA2626357A1 (en) * 2005-10-20 2007-04-26 Nastech Pharmaceutical Company Inc. Intranasal administration of rapid acting insulin
US20090325860A1 (en) 2006-08-04 2009-12-31 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
FR3014694B1 (en) * 2013-12-13 2016-11-11 Roquette Freres METHYL-CYCLODEXTRIN-BASED COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES BY INCREASING THE CHOLESTEROL-HDL RATE
FR3042501B1 (en) * 2015-10-16 2017-11-03 Roquette Freres NOVEL METHYLATED CYCLODEXTRINS AND PROCESSES FOR THEIR PREPARATION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094157B1 (en) * 1982-04-30 1987-07-29 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its use
EP0308181A1 (en) * 1987-09-14 1989-03-22 Novo Nordisk A/S Trans-mucosal delivery formulations and a method for preparation thereof
JPH01117825A (en) * 1987-10-28 1989-05-10 Sanwa Kagaku Kenkyusho Co Ltd Pharmaceutical for nasal cavity and paranasal sinuses administration and use, form and use tool thereof
JP2921872B2 (en) * 1989-08-28 1999-07-19 和光純薬工業株式会社 Transmucosal preparation
NL9001681A (en) * 1990-07-24 1992-02-17 Rijksuniversiteit TRANSMUCOSAL MEDICINAL PRODUCT PREPARATIONS AND TRANSMUCOSAL ADMINISTRATION.
DK49791D0 (en) * 1991-03-20 1991-03-20 Novo Nordisk As NASAL POWDER PREPARATION

Also Published As

Publication number Publication date
BE1006873A6 (en) 1995-01-10
WO1994022461A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
AU664807B2 (en) Drug delivery system
AU7676894A (en) Convection-enhanced drug delivery
AU5676596A (en) Oral insulin delivery
AU5945296A (en) Medicament for nasal administration
AU4989993A (en) Drug delivery system
AU2911695A (en) Inplantable drug delivery pump
AU8538991A (en) Delivery device for atomized medicaments
AU6167894A (en) Intrapulmonary delivery of hormones
AU2399092A (en) Aerosol delivery system
AU3204995A (en) Closed drug delivery system
AU3050892A (en) Delivery system
AU3560495A (en) Medicament inhaler
AU5456598A (en) Insulin delivery enhanced by coached breathing
AU4101693A (en) Subcutaneous implantable multiple agent delivery system
AU6379294A (en) Nasal pharmaceutical composition containing a progestational agent
IL110588A (en) Bioadhesive emulsion preparations for enhanced drug delivery
AU8253791A (en) Delivery catheter
AU7840994A (en) Active substance delivery system
AU7247894A (en) Liquid delivery apparatus
AU4642393A (en) Medication sprayer
AU2999995A (en) Self-emulsifying drug delivery system
AU3154895A (en) Tastemasked liquid pharmaceutical delivery system
AU660290B2 (en) Multiple drug delivery system
AU2345695A (en) Pharmaceutical composition for transdermal delivery
AU6428994A (en) Formulation for nasal insulin delivery